Dividend stocks are the best option for investors looking for steady passive income. These are companies with stable cash flows, healthy balance sheets, and a long history of rewarding shareholders with consistent dividends. Here are two solid dividend stocks that excel at providing consistent income and long-term stability, even in volatile markets.
Johnson & Johnson (JNJ) is a global healthcare company that manufactures prescription drugs to treat serious and chronic diseases and also manufactures medical devices and technologies used in hospitals. JNJ’s diversified business generates stable, resilient income and strong cash flow, allowing it to pay recurring dividends. JNJ has been paying and increasing dividends for more than six decades, earning it the title of Dividend King. Its forward yield of 2.5% is higher than the healthcare average of 1.6%. Its term payment ratio of 42% is also reasonable.
In the third quarter, Johnson & Johnson reported sales of $24 billion globally, representing year-over-year (YoY) growth of 5.4%, despite a major headwind from the loss of STELARA exclusivity. Adjusted net earnings grew to $6.8 billion, with adjusted diluted earnings per share of $2.80, up 15.7% year over year. Free cash flow generation remained strong, reaching $14 billion in the first nine months of the year, allowing the company to fund innovation while maintaining returns for shareholders.
JNJ also announced its intentions to spin off its Orthopedics business, forming a more concentrated healthcare innovation company focused on six key growth areas: oncology, immunology, neuroscience, cardiovascular, surgery and vision. Management noted that the separation is expected to boost MedTech’s growth and margins without having any impact on the company’s dividend. The company ended the quarter with $19 billion in cash and marketable securities and reiterated its commitment to disciplined capital allocation. Despite significant investments in R&D and strategic growth efforts, management has clearly stated that Johnson & Johnson’s dividend will not be affected.
Looking ahead, management expects revenue to grow more than 5% in 2026, and profitability could increase due to new product launches and improving margins. Johnson & Johnson remains an exceptional dividend stock for investors seeking consistent passive income backed by strong fundamentals.
Overall, Wall Street rates JNJ stock a consensus “Moderate Buy.” Of the 25 analysts covering the stock, 13 rate it a “Strong Buy”, two rate it a “Moderate Buy” and 10 rate it a “Hold.” The average price target for the stock is $213.21, 1.6% above current levels. Meanwhile, its high price target of $240 implies a potential upside of 14.4% over the next 12 months.
www.barchart.com
Procter & Gamble (PG) is a global consumer goods company that makes everyday products that people use in the home, often daily, such as household and cleaning products, personal care and grooming, and baby, feminine and family care. P&G owns some of the world’s most trusted brands, sold in more than 180 countries. Consumers often stick with these brands for several years, resulting in strong pricing power and brand loyalty. This business model has generated consistent cash flows and reliable profits, allowing it to pay and increase dividends for the past 69 consecutive years.
It also pays a higher yield of 2.9% compared to the consumer staples sector average of 1.89%. Its forward payment ratio of 57.5% is reasonable and sustainable for a mature consumer staples company like P&G. It allows the company to reinvest in the business, fund innovation and marketing, pay down debt, and ensure consistent dividend growth over time.
In the first quarter of fiscal 2026, P&G earnings rose 21% to $1.95 per share. In the quarter, an adjusted free cash flow productivity of 102% showed that the company is converting profits into cash very efficiently, which strengthens the security of dividends and the company’s ability to pay cash to shareholders without strain.
In particular, it paid $2.55 billion in dividends and $1.25 billion in share buybacks to shareholders. Because P&G makes everyday products that households depend on, generating consistent profits over the long term, it is considered one of the safest and most defensive stocks on the market.
Currently, PG stock has a “Moderate Buy” rating on Wall Street. Of the 24 analysts covering PG, 10 have a “Strong Buy” rating, three say it is a “Moderate Buy” and 11 rate it a “Hold.” Based on the average price target of $166.95, PG stock has a 16.3% upside potential from current levels. Furthermore, its high price target of $181 implies an upside potential of 26.1% over the next 12 months.
www.barchart.com
On the date of publication, Sushree Mohanty had no (directly or indirectly) positions in any of the securities mentioned in this article. All information and data in this article are for informational purposes only. This article was originally published on Barchart.com
